Obagi Medical Products & VelocityShares Daily Inverse VIX Short Term ETN Trend Review: (NASDAQ:OMPI), (NYSE:XIV)
Obagi Medical Products, Inc. (NASDAQ:OMPI) announced that it entered into a definitive merger agreement with Valeant Pharmaceuticals International, Inc. (NYSE: VRX) under which Valeant will acquire all of the outstanding common stock of Obagi for $19.75 per share in cash.
View full press release